Polycystic ovary syndrome: A review for dermatologists : Part II. Treatment - 16/10/14
Abstract |
Dermatologists are in a key position to treat the manifestations of polycystic ovary syndrome (PCOS). The management of PCOS should be tailored to each woman's specific goals, reproductive interests, and particular constellation of symptoms. Therefore, a multidisciplinary approach is recommended. In part II of this continuing medical education article, we present the available safety and efficacy data regarding treatments for women with acne, hirsutism, and androgenetic alopecia. Therapies discussed include lifestyle modification, topical therapies, combined oral contraceptives, antiandrogen agents, and insulin-sensitizing drugs. Treatment recommendations are made based on the current available evidence.
Le texte complet de cet article est disponible en PDF.Key words : acne, androgenetic alopecia, combined oral contraceptive pills, cyproterone acetate, drospirenone, hirsutism, insulin-sensitizing drugs, polycystic ovary syndrome, spironolactone
Abbreviations used : cOCP, CPA, EE, FDA, FG, ISD, PCOS, SHBG, TZD, VTE
Plan
Funding sources: None. |
|
Conflicts of interest: None declared. |
Vol 71 - N° 5
P. 859.e1-859.e15 - novembre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?